Search Results - "McFerran, B A"

Lack of bioeffects of ultrasound energy after intravenous administration of FS069 (Optison) in the anesthetized rabbit by Killam, A. L, Greener, Y, McFerran, B. A, Maniquis, J, Bloom, A, Widder, K. J, Dittrich, H. C

“…The current study was designed to provide a sensitive in vivo model to maximize the potential bioeffects (measured by hemolysis) of B‐mode ultrasound energy in…”
Get full text

Myocardial contrast echocardiography in experimental coronary artery occlusion with a new intravenously administered contrast agent by Dittrich, H C, Bales, G L, Kuvelas, T, Hunt, R M, McFerran, B A, Greener, Y

“…A new intravenously administered ultrasound contrast agent was studied in eight dogs during intermittent coronary artery occlusion. The area of the myocardial…”
Get more information

Tissue distribution of 125I-labeled albumin in rats, and whole blood and exhaled elimination kinetics of octafluoropropane in anesthetized canines, following intravenous administration of OPTISON® (FS069) by KILLAM, A. L, MEHLHAFF, P. M, ZAVORSKAS, P. A, GREENER, Y, MCFERRAN, B. A, MILLER, J. J, BURRASCANO, C, JABLONSKI, E. G, ANDERSON, L, DITTRICH, H. C

Get full text

Tissue Distribution of super(125)I-Labeled Albumin in Rats, and Whole Blood and Exhaled Elimination Kinetics of Octafluoropropane in Anesthetized Canines, Following Intravenous Administration of OPTISON registered (FS069) by Killam, AL, Mehlhaff, P M, Zavorskas, P A, Greener, Y, McFerran, BA, Miller, J J, Burrascano, C, Jablonski, E G, Anderson, L, Dittrich, H C

“…OPTISON, an agent being developed as an intravenous (IV) ultrasound contrast agent, consists of a suspension of octafluoropropane (OFP)-containing albumin…”
Get full text